Example applications

PGDx offers cancer genome analysis services from early discovery through clinical trials and beyond for academics, biotechnology and pharmaceutical companies, and contract research organizations (CROs).

We combine cancer genetics and next-generation sequencing to help researchers identifymolecular alterations responsible for how cancers grow, invade, and metastasize, or how they are sensitive or resistant to various therapies.

Our services help in developing prognostic and diagnostic markers and identifying genetic predisposition to disease, therapeutic targets, and modulators of therapeutic efficacy such as resistance mutations, synthetic lethality, and modifier genes. See project examples below.